Expertise in
12
conditions

Yves Reznik

Caen, FR 
Expertise in
12
conditions
Caen, FR 

Overview

Yves Reznik practices practicing medicine in Caen, France.

Mr. Reznik is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Low Blood Sugar, Type 1 Diabetes (T1D), Maturity Onset Diabetes of the Young, and Hormone Replacement Therapy (HRT).

He is actively involved in clinical research, co-authoring 133 peer reviewed articles and participating in 7 clinical trials.

Gender

Male

Locations

Caen, France
Other Locations
Dijon, France
Le Mans, France
Grenoble, France
Paris, 75012, France
Cannes, 14033, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Randomized Trial to Assess the Efficacy of a High-intensity Physical Activity Program on Renal Function Decline in High Risk Patients With Type 2 Diabetes
Randomized Trial to Assess the Efficacy of a High-intensity Physical Activity Program on Renal Function Decline in High Risk Patients With Type 2 Diabetes
Enrollment Status: Terminated
Publish Date: April 09, 2025
Intervention Type: Other
Study Phase: Not Applicable
ADvanced Hybrid Closed Loop Study in Adult Population With Type 1 Diabetes
ADvanced Hybrid Closed Loop Study in Adult Population With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: March 27, 2023
Intervention Type: Device, Other
Study Phase: Not Applicable
Effect of Neuromuscular Electrostimulation on Sympathetic Nerve Activity in Patients With Type 2 Diabetes (ELECTROSYMP2)
Effect of Neuromuscular Electrostimulation on Sympathetic Nerve Activity in Patients With Type 2 Diabetes (ELECTROSYMP2)
Enrollment Status: Withdrawn
Publish Date: August 24, 2022
Intervention Type: Device, Other
Study Phase: Not Applicable
Validation of a Predictive Risk Equation for Type 2 Diabetes in Children With Diabetes to Achieve a Predictive Diagnostic Biochip for the Early Detection of Individuals at Risk in Families.
Validation of a Predictive Risk Equation for Type 2 Diabetes in Children With Diabetes to Achieve a Predictive Diagnostic Biochip for the Early Detection of Individuals at Risk in Families.
Enrollment Status: Completed
Publish Date: May 11, 2021
Intervention Type: Other
Study Phase: Not Applicable
Safety Assessment of DBLUS System in Adolescent and Adult Patients With Type 1 Diabetes and Assessment of Its Clinical Efficacy in a Randomized Trial for 3 Months Followed by an Extension Period
Safety Assessment of DBLUS System in Adolescent and Adult Patients With Type 1 Diabetes and Assessment of Its Clinical Efficacy in a Randomized Trial for 3 Months Followed by an Extension Period
Enrollment Status: Terminated
Publish Date: April 08, 2021
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen
Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen
Enrollment Status: Completed
Publish Date: August 21, 2018
Intervention Type: Device
Study Phase: Not Applicable
Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid Adenomas
Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid Adenomas
Enrollment Status: Completed
Publish Date: January 04, 2018
Intervention Type: Radiation
Study Phase: Phase 2
View 6 Less Clinical Trials

133 Total Publications

The risk of nephrotic range proteinuria and kidney failure in primary laminopathies is genotype-specific.
The risk of nephrotic range proteinuria and kidney failure in primary laminopathies is genotype-specific.
Journal: JCI insight
Published: July 16, 2026

Frequently Asked Questions about Yves Reznik

Is Yves Reznik a top-rated expert for Type 2 Diabetes (T2D)?

MediFind is an objective health platform that identifies experts based on real-world data. Yves Reznik is classified as an Distinguished expert for Type 2 Diabetes (T2D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yves Reznik participate in research or clinical trials?

Yes. Yves Reznik has published 133 articles and abstracts on conditions like Type 2 Diabetes (T2D). You can view a list of Yves Reznik's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Reznik's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 41 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile